Forty1's ‘Morphex’ applies innovative Behavioral Algorithm to transform the way people experience business change

Greenphire Launches Research Registry App Allowing Foundations and Advocacy Groups to Better Engage and Support Patient Communities

Registry builds upon the company's robust patient-centric suite of solutions with expanded mobile capabilities and feature functionality depth

PubHive Upgrades SaaS Platform’s MedDRA Integration to Version 26

Drug safety and pharmacovigilance (DSPV) teams that license access to the PubHive Navigator platform can now access the newest MedDRA version when performing signal evaluation and reporting activities.

Samsung Biologics announces construction of Plant 5 to commence Bio Campus II capacity expansion

Samsung Biologics (KRX: 207940.KS), a leading contract development and manufacturing organization (CDMO), announced today that the company will commence the construction of a fifth plant as part of its strategic expansion in response to increased market demand.

Vaxess Hires Steve Bende, Ph.D., as Chief Strategy Officer

Former global head of new products at Sanofi Pasteur to lead Vaxess’s business and product development strategy

Alfa Chemistry Renews Supply of Rare Earth Acetates

The Working Principle and Applications of Ion Exchange Resin

CD Formulation Supplies Active Ingredients, Antioxidants, and Chelating Chemicals for Cosmetic Industry

Quantitative Analysis of ADC Components - Ligand Binding Assay (LBA) and LC-MS/MS

There are both large and small ADC molecules. A variety of biological analysis methods and platforms are needed to analyze the diversity of ADCs.

Survey Reveals Older Adults Eager to Get Ahead of Alzheimer's and Other Dementias; Industry Lags

92% of participants want to know about Alzheimer’s early according to new Linus Health report

Altasciences Selects Proscia To Accelerate The Development Of Life-Saving Drugs

Driving more complete decisions for biopharmaceutical companies with modern digital pathology

Proscia Announces Major Expansion In Preclinical R&D To Drive Faster Drug Safety Decisions

Flagship software platform further unifies pathology workflows and data across the R&D value chain

LIQUID STABLE CLINICAL ENZYME CALIBRATION VERIFIERS FOR AMYLASE & LIPASE TESTING NOW AVAILABLE FROM VERICHEM

VERICHEM LABORATORIES now offers multi-level calibration verification materials for amylase and lipase activity as part of its liquid stable, ready-to-use Enzyme ER™ Verifier Kit.

Clinical Pharmacology of Antibody-Drug Conjugates

BOC Sciences Confirms Bulk Offering of Pharmaceutical Impurities for Global Partners

In the wake of the COVID-19 pandemic, BOC Sciences, the world's reputed chemical supplier, declares that it will increase production to offer pharmaceutical impurity standards in bulk to satisfy unmet demands.

Inizio strengths senior team with DE&I appointment

International strategic health and life science specialists Inizio have increased their organizational-wide focus on diversity, equity, and inclusion with the appointment of Stefanie Christmas as their new Global Head of Diversity, Equity & Inclusion (DE&I).

BioIVT to Highlight its Drug-Drug Interaction and ADME Research Expertise at the SOT Annual Meeting and ToxExpo

It will provide strategies to de-risk each stage of the R&D pipeline, with particular focus on regulatory drivers, investigatory objectives, and practical concerns that are relevant to toxicologists.

Recipharm's Arranta Bio expands RNA process development capacity by 50 percent to meet increased customer demand

Arranta Bio, a Recipharm company and leading contract development and manufacturing organization (CDMO) supporting advanced therapy pioneers, has announced that it has doubled capacity at its Watertown, MA facility for process development services supporting RNA therapeutics.

Mural Health and ProofPilot Partner to Streamline Payments and Provide More Patient Choice

Mural Health, a clinical trials technology company that improves the patient and caregiver experience in order to improve enrollment rates, participant retention, and increase protocol compliance and ProofPilot, the industry's first digital protocol automation platform for clinical trial, today announced a strategic partnership to further advance clinical trial operations for life science customers. Through this partnership, Mural Health’s Mural Link™ platform and ProofPilot’s platform work together to progress clinical operations and materially improve the efficiency, and outcomes, of global clinical trials.

Implanting a Better Future: Navigating the Changing Dynamics of the Medical Implant Industry

The COVID-19 pandemic has had a major impact on the implant industry, both positively and negatively. Here are some of the main effects: